Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Tarsus Pharmaceuticals, Inc. | 43 316 | déclaré | 19 mars 2026 | tx 25+532 071−111 030 |
| Global Blood Therapeutics, Inc. | 0 | déclaré | 05 oct. 2022 | tx 120+575 057−708 197 |
| HYPERION THERAPEUTICS INC | 0 | déclaré | 07 mai 2015 | tx 25+270 027−413 521 |
| RENOVIS INC | 0 | déclaré | 02 mai 2008 | tx 8+36 250−110 744 |
| ZS Pharma, Inc. | 0 | déclaré | 17 déc. 2015 | tx 2−85 000 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 19 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 2 186 | 67.00 USD | |
| 17 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 2 111 | 69.42 USD | |
| 18 mars 2026 | SALE | Tarsus Pharmaceuticals, Inc. | 2 133 | 68.71 USD | |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 13 042 | — | |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8 020 | 0.00 USD | deriv |
| 15 mars 2026 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 5 022 | 0.00 USD | deriv |
| 05 mars 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 19 306 | 0.00 USD | deriv |
| 05 mars 2026 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 30 724 | 0.00 USD | deriv |
| 16 juin 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 27 881 | — | |
| 17 juin 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 13 608 | 40.42 USD | |
| 16 juin 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 27 881 | 0.00 USD | deriv |
| 18 mars 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 1 284 | 46.29 USD | |
| 19 mars 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 1 254 | 47.40 USD | |
| 20 mars 2025 | SALE | Tarsus Pharmaceuticals, Inc. | 1 186 | 50.11 USD | |
| 15 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8 019 | — | |
| 17 mars 2025 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 8 019 | 0.00 USD | deriv |
| 05 mars 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 30 628 | 0.00 USD | deriv |
| 05 mars 2025 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 20 089 | 0.00 USD | deriv |
| 17 juin 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 27 881 | — | |
| 18 juin 2024 | SALE | Tarsus Pharmaceuticals, Inc. | 10 445 | 27.47 USD | |
| 17 juin 2024 | EXERCISE | Tarsus Pharmaceuticals, Inc. | 27 881 | 0.00 USD | deriv |
| 07 mars 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 47 500 | 0.00 USD | deriv |
| 07 mars 2024 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 32 079 | 0.00 USD | deriv |
| 24 avr. 2023 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 111 525 | 0.00 USD | deriv |
| 24 avr. 2023 | GRANT_AWARD | Tarsus Pharmaceuticals, Inc. | 163 397 | 0.00 USD | deriv |